Sio Gene Therapies Odds of Future Stock Price Finishing Over 0.40

SIOXDelisted Stock  USD 0.40  0.01  2.56%   
Sio Gene's future price is the expected price of Sio Gene instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Sio Gene Therapies performance during a given time horizon utilizing its historical volatility. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
  
Please specify Sio Gene's target price for which you would like Sio Gene odds to be computed.

Sio Gene Target Price Odds to finish over 0.40

The tendency of Sio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.40 90 days 0.40 
over 95.68
Based on a normal probability distribution, the odds of Sio Gene to move above the current price in 90 days from now is over 95.68 (This Sio Gene Therapies probability density function shows the probability of Sio Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Sio Gene Therapies has a beta of -0.28. This usually implies as returns on the benchmark increase, returns on holding Sio Gene are expected to decrease at a much lower rate. During a bear market, however, Sio Gene Therapies is likely to outperform the market. Additionally Sio Gene Therapies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Sio Gene Price Density   
       Price  

Predictive Modules for Sio Gene

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sio Gene Therapies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.400.400.40
Details
Intrinsic
Valuation
LowRealHigh
0.350.350.44
Details
Naive
Forecast
LowNextHigh
0.400.400.40
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.400.410.42
Details

Sio Gene Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sio Gene is not an exception. The market had few large corrections towards the Sio Gene's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sio Gene Therapies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sio Gene within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.07
β
Beta against Dow Jones-0.28
σ
Overall volatility
0.02
Ir
Information ratio -0.12

Sio Gene Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sio Gene for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sio Gene Therapies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Sio Gene Therapies is not yet fully synchronised with the market data
Sio Gene Therapies has some characteristics of a very speculative penny stock
Sio Gene Therapies has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (71.89 M) with profit before overhead, payroll, taxes, and interest of 0.
Sio Gene Therapies currently holds about 54.77 M in cash with (60.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 25.0% of the company outstanding shares are owned by corporate insiders

Sio Gene Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sio Stock often depends not only on the future outlook of the current and potential Sio Gene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sio Gene's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding73.2 M
Cash And Short Term Investments63.7 M

Sio Gene Technical Analysis

Sio Gene's future price can be derived by breaking down and analyzing its technical indicators over time. Sio Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sio Gene Therapies. In general, you should focus on analyzing Sio Stock price patterns and their correlations with different microeconomic environments and drivers.

Sio Gene Predictive Forecast Models

Sio Gene's time-series forecasting models is one of many Sio Gene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sio Gene's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Sio Gene Therapies

Checking the ongoing alerts about Sio Gene for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sio Gene Therapies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sio Gene Therapies is not yet fully synchronised with the market data
Sio Gene Therapies has some characteristics of a very speculative penny stock
Sio Gene Therapies has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (71.89 M) with profit before overhead, payroll, taxes, and interest of 0.
Sio Gene Therapies currently holds about 54.77 M in cash with (60.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 25.0% of the company outstanding shares are owned by corporate insiders
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Sio Stock

If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated